• Giordana de Cássia Pinheiro da Motta, Juliana Machado Schardosim, and Maria Luzia Chollopetz da Cunha.
• Clinical Hospital of Porto Alegre, Porto Alegre, Brazil. Electronic address: giordanamotta@yahoo.com.br.
• J Pain Symptom Manage. 2015 Sep 1; 50 (3): 394-401.

ContextThe Neonatal Infant Pain Scale (NIPS), initially developed in Canada, has been previously used but not adequately adapted and validated for use in Brazil.ObjectivesThe goal of the present study was to perform a cross-cultural adaptation and clinical validation of the NIPS for use in the Brazilian population.MethodsThe instrument was adapted based on the method outlined by Beaton et al., including the production and combination of translated versions, back-translation, committee review, and pilot testing. The psychometric properties of the adapted instrument, including its validity, reliability, and internal consistency, were tested in a clinical validation study. The sample comprised 60 at-term newborns who were evaluated by six nurses as they experienced vaccination. Psychometric properties were evaluated using Student's t-tests, prevalence-adjusted and bias-adjusted kappa scores, the Bland-Altman method, and Cronbach's alpha coefficients.ResultsThe Brazilian version of the NIPS (Escala de Dor no Recém-Nascido [NIPS-Brazil]) demonstrated excellent interobserver and intraobserver reliability. Total NIPS-Brazil scores yielded prevalence-adjusted and bias-adjusted kappa scores of 0.93, whereas the Bland-Altman method revealed interobserver and intraobserver reliability values of 95% and 90%, respectively. The NIPS-Brazil had adequate internal consistency, as evidenced by a Cronbach's alpha of 0.762.ConclusionThe NIPS was successfully adapted for use in Brazil and is now available for use in the assessment of acute pain in at-term newborns in Brazil.Copyright © 2015 American Academy of Hospice and Palliative Medicine. Published by Elsevier Inc. All rights reserved.

23 keywords...

hide…